Strength
200 mg/1
Manufacturer
Gilead Sciences, Inc.NDC
61958060101
Classification
Brand
Dosage Form
CAPSULE
Route
ORAL
Last Updated
4/22/2026
Active Ingredients
EMTRICITABINEApproval Type
New Drug (NDA)
FDA Application
NDA021500On Market Since
7/2/2003
Pharmacological Classes
Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor
Nucleoside Reverse Transcriptase Inhibitors
Nucleosides
Generic Alternatives
No alternatives available
No alternatives found with the same active ingredient, strength, and dosage form.
Related Drugs
Same classification
EPIVIR 10 MG/ML ORAL SOLN
Brand
49702020548•ViiV Healthcare Company
$0.4452
per ML
ZIAGEN 20 MG/ML SOLUTION
Brand
49702022248•ViiV Healthcare Company
$0.5865
per ML
EPIVIR 150 MG TABLET
Brand
49702020318•ViiV Healthcare Company
$6.6144
per EA
IMURAN 50 MG TABLET
Brand
54766059010•Sebela Pharmaceuticals Inc.
$8.8907
per EA
INTELENCE 100 MG TABLET
Brand
59676057001•Janssen Products LP
$10.9213
per EA
EPIVIR 300 MG TABLET
Brand
49702020413•ViiV Healthcare Company
$13.2940
per EA
COMBIVIR TABLET
Brand
49702020218•ViiV Healthcare Company
$14.3948
per EA
INTELENCE 200 MG TABLET
Brand
59676057101•Janssen Products LP
$24.2861
per EA
VIREAD 300 MG TABLET
Brand
61958040101•Gilead Sciences, Inc.
$40.7318
per EA
BARACLUDE 1 MG TABLET
Brand
00003161212•E.R. Squibb & Sons, L.L.C.
$43.9221
per EA